Corporis Medical is delighted to announce that it has formed a consortium with AIM BV (The Netherlands) and CSEM SA (Switzerland) with the goal to further develop our Perfusion Measurement technology towards a commercial device. The consortium has been awarded with funding from the EUROSTARS program, an EU Horizon 2020 initiative that supports research-performing small and medium enterprises.

​

The project titled “PREV-ALE”aims to further develop an Anastomotic Perfusion Measurement Device (APM) which, during surgery, will be able to measure tissue healing capability. The technology allows already during surgery to predict the risk of ischemic tissue and with that the risk of anastomotic leakage (AL) after surgery. We believe that this will change the surgical field by improving safety and efficacy, whilst reducing complications and costs. 
 
During the two years' grant period, each partner of this multidisciplinary consortium will contribute its expertise to reach their shared goal. Corporis Medical, the inventor of the APM technology will contribute its clinical research and design competences. AIM, an independent contract manufacturer in medical devices and instruments will contribute to building prototypes for testing. CSEM, a private research and technology organization will contribute its expertise and competenciesin microtechnology, sensor technology and electronics.  
 
John Marugg, CEO of Corporis Medical, comments “This consortium will allow us to bring all required competences together needed to further develop, test and manufacture the commercial device. The reviewers of our EUROSTARS grant application were all very excited about the technology and the impact it could have on reducing AL and saving lives.”
 
Alexander Veenhof, CSO of Corporis Medical and gastrointestinal surgeon; “finally we will be able to locate the optimum location for a new anastomosis during bowel surgery and subsequently prevent many leakages from occurring.”

​

About Corporis Medical

Formerly known as Health Value Creation, Corporis Medical is a Dutch medical device company that aims to overhaul the surgery field by providing innovative solutions for surgery. With a first focus is on the abdominal surgery field, Corporis Medical aims to develop products that fulfill the current unmet needs in this respective field and in doing so, improve the safety and efficacy of abdominal surgeries. These solutions will not only help reduce abdominal surgery accompanied healthcare costs, but also save thousands of lives.

​

About CSEM SA

CSEM SA is a Swiss, non-profit research and development centre specializing in micro- and nanotechnology, systems engineering, photovoltaics, microelectronics, and communications technologies. CSEM is a national innovation accelerator—a catalyst for the transfer of technologies and know-how from fundamental research to industry. The markets it supplies range from automotive and machine tools, to medicine and space exploration, offering its customers innovative solutions based on their knowledge of the market and the technological expertise derived from applied research.

​

About AIM BV

AIM BV is a specialist in producing professional medical instruments and equipment. Located in Brunssum, Limburg, they offer production services to product owners with a focus on marketing and sales. AIM can manage the entire production of new or existing medical equipment. The company cooperates  with different specialized partners in the fields of product development, design, and certification. This way AIM can offer their valued customers state of the art knowledge while focusing on the core business: producing high qualitative medical instruments and equipment.  

​

About EUROSTARS

Eurostars supports international innovative projects led by research and development- performing small- and medium-sized enterprises (R&D-performing SMEs). With its bottom-up approach, Eurostars supports the development of rapidly marketable innovative products, processes and services that help improve the daily lives of people around the world. Eurostars has been carefully developed to meet the specific needs of SMEs. It is an ideal first step in international cooperation, enabling small businesses to combine and share expertise and benefit from working beyond national borders.

​

 

​

 

​

​

​

​

​

​